Sökning: "T-ALL"
Visar resultat 11 - 15 av 24 avhandlingar innehållade ordet T-ALL.
11. Minimal Residual Disease Assessment in Childhood Acute Lymphoblastic Leukemia
Sammanfattning : Traditionally, response to treatment in hematological malignancies is evaluated by light microscopy of bone marrow (BM) smears, but due to more effective therapies more sensitive methods are needed. Today, detection of minimal residual disease (MRD) using immunological and molecular techniques can be 100 times more sensitive than morphology. LÄS MER
12. Apoptosis signaling in leukemia and lymphoma: understanding mechanisms of chemoresistance
Sammanfattning : Apoptosis (programmed cell death) is a basic physiological process, essential in the balance between life and death of cells of normal tissues in the body. Apoptosis can be considered as cellular “suicide” initiated by the cell itself when infected by a virus or transformed into a cancer cell. LÄS MER
13. Cell death mechanisms of anti-cancer agents and treatment response in acute leukemia
Sammanfattning : Acute leukemia (AL) is a fatal disease, which causes rapid death in the absence of appropriate chemotherapeutic intervention. Long-term survival rates vary from 80% in childhood lymphoblastic AL (ALL) to 10-20% in adult myeloid AL (AML). LÄS MER
14. Studies of Cytotoxic Compounds of Natural Origin and their Mechanisms of Action
Sammanfattning : Cancer incidence is increasing and novel anticancer drugs with new mechanisms of action are essential for future chemotherapeutic treatment. Natural products have historically played an important role in the development of anti-cancer drugs and have potential to do so also in the future. LÄS MER
15. Genomic characterization of pediatric acute lymphoblastic leukemia by deep sequencing
Sammanfattning : Acute Lymphoblastic Leukemia (ALL) is the most common cancer in children, with close to 200 cases per year in the Nordic countries. Despite recent advances in modern chemotherapies, 20% of the ALL patients experience a relapse. LÄS MER